Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03455660 · ClinicalTrials.gov registry record

A Retrospective Comparison of Neonatal Acid-base Status After CD Before January, 2015 and After January, 2016

A clinical trial of Cesarean Delivery, sponsored by Columbia University.

Completed
Registry status
101
Enrollment target
1
Study location

NCT03455660 is a study of Cesarean Delivery that has completed, run by Columbia University. The registered enrollment target is 101 participants, below the 3,473-participant average among 10 other Cesarean Delivery trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03455660, a study of Cesarean Delivery, has completed, sponsored by Columbia University.

COMPLETED
Registry status
101 participants
Enrollment target
1
Study location

Study Summary

The objective is to retrospectively gather peri-operative data on neonatal outcomes, primarily neonatal acid-base status, based on umbilical cord gas analysis, for the 23 months preceding and 23 months following the conduct of the "tilt versus supine study". The investigators hypothesize that there will be no difference in mean neonatal umbilical artery base excess in neonates delivered by cesarean section during the period before and after conduct of the study, for elective, urgent and emergent deliveries.

Conditions Studied

Interventions

  • OTHER no intervention

Study Locations (1)

New York

  • NewYork Presbyterian/The Allen Hospital - New York

Trial Details

FieldValue
Enrollment Target 101 participants
Start Date 2014-12
Est. Completion 2016-01

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT03455660

The ClinicalTrials.gov registry entry for NCT03455660 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,473-participant average among 10 other Cesarean Delivery trials with a reported enrollment target (97% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cesarean Delivery appearing as the primary indexed condition, and to 1 intervention - of which no intervention is the first listed.

NCT03455660 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03455660 about?

NCT03455660 is a clinical study titled "A Retrospective Comparison of Neonatal Acid-base Status After CD Before January, 2015 and After January, 2016". The objective is to retrospectively gather peri-operative data on neonatal outcomes, primarily neonatal acid-base status, based on umbilical cord gas analysis, for the 23 months preceding and 23 months following the conduct of the "tilt versus supine study". The investigators hypothesize that there ...

What is the current status of trial NCT03455660?

This trial is currently completed. The enrollment target is 101 participants. The study started on 2014-12. Estimated completion is 2016-01.

What conditions does trial NCT03455660 study?

This clinical trial studies the following conditions: Cesarean Delivery.

What interventions are being tested in trial NCT03455660?

The interventions under investigation include: no intervention (OTHER).

Who is sponsoring clinical trial NCT03455660?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03455660 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cesarean Delivery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.